Vaginal progesterone in the treatment of cervical dysplasia grade I and II: A phase II trial.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Progesterone (Primary)
- Indications Cervical cancer; Cervical dysplasia
- Focus Therapeutic Use
- 09 Mar 2012 Biomarkers information updated
- 08 Mar 2012 Additional lead trial investigator (Lukas A Hefler) identified as reported by ClinicalTrials.gov.
- 08 Mar 2012 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.